Blood clot prevention drug, Savaysa, gets FDA approval

January 9, 2015 7:17 PM

6 0

Blood clot prevention drug, Savaysa, gets FDA approval

The U.S. Food and Drug Administration today approved the anti-clotting drug Savaysa (edoxaban tablets) to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.

Atrial fibrillation is one of the most common types of abnormal heart rhythm. It occurs when the heart’s two upper chambers (atria) do not contract properly, allowing blood clots to form, which can break off and travel to the brain or other parts of the body. Patients with atrial fibrillation experi...

Read more

To category page

Loading...